Heterogeneity of Clazosentan Benefit after Aneurysmal Subarachnoid Hemorrhage Demonstrated in an Externally Validated Causal Policy Tree.
- DOI
- 10.1007/s12028-026-02573-5
- Published
- 2026 Jun 17
- Container
- Neurocritical care
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12028-026-02573-5,
title = {Heterogeneity of Clazosentan Benefit after Aneurysmal Subarachnoid Hemorrhage Demonstrated in an Externally Validated Causal Policy Tree.},
author = {Nishida K and Chrétien B and Muraoka S and Izumi T and Nishihori M and Goto S and Takeuchi I and Tashiro R and Sakata H and Vivien D and Mizuno M and Endo H and Saito R},
year = {2026},
journal = {Neurocritical care},
doi = {10.1007/s12028-026-02573-5},
url = {https://doi.org/10.1007/s12028-026-02573-5}
}RIS
TY - JOUR TI - Heterogeneity of Clazosentan Benefit after Aneurysmal Subarachnoid Hemorrhage Demonstrated in an Externally Validated Causal Policy Tree. AU - Nishida K AU - Chrétien B AU - Muraoka S AU - Izumi T AU - Nishihori M AU - Goto S AU - Takeuchi I AU - Tashiro R AU - Sakata H AU - Vivien D AU - Mizuno M AU - Endo H AU - Saito R PY - 2026 JO - Neurocritical care DO - 10.1007/s12028-026-02573-5 UR - https://doi.org/10.1007/s12028-026-02573-5 ER -
APA
K, N., B, C., S, M., T, I., M, N., S, G., I, T., R, T., H, S., D, V., M, M., H, E., & R, S. (2026). Heterogeneity of Clazosentan Benefit after Aneurysmal Subarachnoid Hemorrhage Demonstrated in an Externally Validated Causal Policy Tree.. Neurocritical care. https://doi.org/10.1007/s12028-026-02573-5
Source records
- pubmed · retrieved 2026-09-25T17:08:10.774Z
- europe-pmc · retrieved 2026-09-25T17:08:10.789Z